425: Strive and Semler Scientific Announce Merger Plans

Strive, Inc. and Semler Scientific, Inc. are pursuing a business combination, with Strive issuing Class A common stock.

Summary

• Strive, Inc. and Semler Scientific, Inc. have announced a proposed business combination.
• The communication was posted on X.com by Avik Roy, a Board Member of Strive, Inc., on October 24, 2025.
• The transaction involves Strive issuing additional shares of its Class A common stock.
• The companies anticipate strategic and financial benefits, including potential cost savings, from the proposed merger.
• A Registration Statement on Form S-4, including an Information Statement/Proxy Statement/Prospectus, will be filed with the SEC.
• Semler Scientific stockholders will need to approve the proposed transaction.

Sentiment

Score: 6

Explanation: The filing announces a significant strategic move (merger) with stated benefits, which is generally positive. However, it also includes an extensive cautionary statement detailing numerous risks and uncertainties, balancing the overall sentiment to moderately positive with significant caveats.

Positives

• Anticipated strategic benefits from the proposed transaction.
• Expected financial benefits, including potential cost savings, from the proposed transaction.

Negatives

• Potential for the proposed transaction to be more difficult, time-consuming, or costly than expected.
• Risk of management's attention being diverted from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential for adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing could be negative.

Risks

• The occurrence of any event, change, or other circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that anticipated benefits, including cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with the implementation of Bitcoin treasury strategies and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could impact the transaction.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing.

Future Outlook

The companies anticipate strategic and financial benefits from the proposed transaction, including cost savings, and expect to successfully integrate the combined businesses. The timing of the closing of the proposed transaction is also a forward-looking expectation.

Management Comments

• Avik Roy, Board Member of Strive, Inc., posted a communication on X.com on October 24, 2025, in connection with the proposed business combination.

Industry Context

NA

Stakeholder Impact

• Shareholders of Strive will experience dilution due to the issuance of additional Class A common stock.
• Customers and employees of both Strive and Semler Scientific may experience adverse reactions or changes to their relationships due to the announcement or completion of the proposed transaction.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC.
• The Form S-4 will include an Information Statement of Strive, a Proxy Statement of Semler Scientific, and a Prospectus of Strive.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific to seek their approval of the proposed transaction.

Key Dates

Recommendation

The filing announces a proposed business combination with potential strategic and financial benefits, but also outlines numerous risks including integration difficulties, dilution, and market conditions. Investors should await further details in the S-4 filing and assess the full terms and synergies before making a definitive investment decision.

Keywords

Strive Inc, Semler Scientific Inc, Merger, Acquisition, Business Combination, SEC Filing, Form 425, Bitcoin Treasury Strategy, Corporate Governance